Tech companies gather to discuss A.I. in healthcare
The Consumer Technology Association (CTA) has launched a new initiative that brings major technology companies and health care industry leaders together to examine and set standards for artificial intelligence in health care. The host of companies includes some of the top players in the A.I. Biotech/Diagnostics sector, including Fitbit, Google, Philips, Samsung, and IBM. Their goal is to ultimately enhance health outcomes, improve efficiencies, and reduce health care costs. The patent portfolios of these companies already exemplify the ubiquity of artificial intelligence in the medical diagnostics field, so their discussion is expected to affect not only how data is handled in the future, but also how existing technologies will need to conform to new regulations.
Related Posts
Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…
Capital One is Investing in AI Biotech? What’s in their wallet?
In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…
Google AI Reinvents Speech Recognition. Who will follow?
There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…